SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-244422
Filing Date
2018-08-09
Accepted
2018-08-09 16:32:12
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d585259d10q.htm 10-Q 695109
2 EX-10.3 d585259dex103.htm EX-10.3 24958
3 EX-31.1 d585259dex311.htm EX-31.1 6253
4 EX-31.2 d585259dex312.htm EX-31.2 6257
5 EX-32.1 d585259dex321.htm EX-32.1 6128
  Complete submission text file 0001193125-18-244422.txt   2876784

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zfgn-20180630.xml EX-101.INS 448179
7 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20180630.xsd EX-101.SCH 33432
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20180630_cal.xml EX-101.CAL 49644
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20180630_def.xml EX-101.DEF 97362
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20180630_lab.xml EX-101.LAB 267875
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20180630_pre.xml EX-101.PRE 180453
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 181005551
SIC: 2834 Pharmaceutical Preparations